Compare Vipshop Holdings Ltd - ADR (VIPS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vipshop Holdings Ltd - ADR vs State Street SPDR S&P Biotech ETF — how do they compare? Vipshop Holdings Ltd - ADR trades at $12.9 (market cap $6.05B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is the larger of the two by market cap, and Vipshop Holdings Ltd - ADR pays a 4.87% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vipshop Holdings Ltd - ADR for 49 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| VIPS | XBI | |
|---|---|---|
Market Cap | $6.05B | $10.11B |
Volume | 3,719,230 | 12,903,266 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $20.29 | $169.55 |
52-Week Low | $12.09 | $104.99 |
Typical Hold Time | 49 Days | 38 Days |
Enterprise Value | $2.87B | — |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vipshop Holdings Limited (VIPS) trades at $12.72, down 0.39% on the day, with a neutral technical signal and bearish moving averages. The company reported Q2 2026 earnings that missed expectations, with revenue of $105.92 billion in 2025 and a net income margin of 9.82%. Valuation ratios appear attractive with a P/E of 4.1 and P/S of 0.4. Analyst consensus is bullish with a $16.17 price target, though recent news highlights a challenging retail environment and cautious consumer sentiment.
The outlook for VIPS is mixed; low valuations and strong profitability metrics offer upside potential, but stagnant revenue growth and macroeconomic headwinds pose risks. Investor sentiment is cautious due to recent earnings misses and soft top-line performance, though institutional interest remains, as seen with Nykredit's $2.35 million position in Q2 2026.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
